HBeAg-negative chronic hepatitis B: why do I treat my patients with pegylated interferon-alfa?
about
Antiviral therapies and prospects for a cure of chronic hepatitis B.Chronic hepatitis B virus in young adults: the need for new approaches to management.New paradigms in hepatitis B management: only diamonds are forever.TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice.
P2860
HBeAg-negative chronic hepatitis B: why do I treat my patients with pegylated interferon-alfa?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
HBeAg-negative chronic hepatit ...... ith pegylated interferon-alfa?
@en
type
label
HBeAg-negative chronic hepatit ...... ith pegylated interferon-alfa?
@en
prefLabel
HBeAg-negative chronic hepatit ...... ith pegylated interferon-alfa?
@en
P2860
P356
P1433
P1476
HBeAg-negative chronic hepatit ...... ith pegylated interferon-alfa?
@en
P2093
Jiannis Vlachogiannakos
P2860
P304
P356
10.1111/LIV.12404
P478
34 Suppl 1
P577
2014-02-01T00:00:00Z